Inhibiting FOXM1 Sensitizes Myeloma Cells to BCL2 Inhibitor Venetoclax By Repressing MYC Pathway

被引：2

作者：

Zhou, Vivian ^{[1
]}

Bachelor, Luke Moat ^{[2
]}

Yu, Manya ^{[1
]}

Parashar, Deepak ^{[1
]}

Shour, Abdul ^{[3
]}

Zhang, Liang ^{[1
]}

Kitchner, Terrie ^{[3
,5
,6
]}

Shukla, Sanjay ^{[3
]}

Guo, Song ^{[4
]}

Ananiev, Gene ^{[4
]}

Katzenellenbogen, Benita S.

Katzenellenbogen, John ^{[7
]}

Onitilo, Adedayo ^{[8
]}

Janz, Siegfried ^{[1
]}

Wen, Zhi ^{[2
]}

机构：

[1] Med Coll Wisconsin, Milwaukee, WI USA

[2] Marshfield Clin Res Inst, Ctr Precis Med Res, Marshfield, WI USA

[3] Marshfield Clin Res Inst, Marshfield, WI USA

[4] Univ Wisconsin Madison, Madison, WI USA

[5] Univ Illinois, Dept Physiol, Ctr Canc, Urbana, IL USA

[6] Univ Illinois, Dept Chem, Ctr Canc, Urbana, IL USA

[7] Univ Illinois, Dept Physiol & Chem, Ctr Canc, Urbana, IL USA

[8] Marshfield Clin Res Fdn, Canc Care & Res Ctr, Marshfield, WI USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180268

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] The Combination of Bcl-2 Inhibitor Venetoclax and Mcl-1 Inhibitor MIK665 induces Cell Death in HCC Cells
Walz, Franziska
Michalski, Marlen
Aschenbrenner, Elisabeth
Mueller-Schilling, Martina
Guelow, Karsten
INTERNIST, 2022, 63 (SUPPL 3): : 328 - 329
[32] HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression
Luo, Cancan
Yu, Tiantian
Young, Ken H.
Yu, Li
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2022, 23 (08): : 666 - 681
[33] Inhibiting Mitochondria Function By Bcl-2 Inhibitor Venetoclax and Complex I Inhibitor Iacs-010759 Eliminate Leukemia Cells in Pre-Clinical AML Models
Zhang, Qi
Lodi, Alessia
Sweeney, Shannon Renee
Han, Lina
Cai, Tianyu
Kuruvilla, Vinitha Mary
Cavazos, Antonio
Ma, Helen
Tabe, Yoko
Marszalek, Joseph R.
Tiziani, Stefano
Konopleva, Marina Y.
BLOOD, 2019, 134
[34] Targeting the PI3K/mTOR Pathway in Lymphoma with PQR309 and PQR620: Single Agent Activity and Synergism with the BCL2 Inhibitor Venetoclax
Tarantelli, Chiara
Gaudio, Eugenio
Hillmann, Petra
Spriano, Filippo
Kwee, Ivo
Rinaldi, Andrea
Stathis, Anastasios
Zucca, Emanuele
Fabbro, Doriano
Cmiljanovic, Vladimir
Bertoni, Francesco
BLOOD, 2016, 128 (22)
[35] OPN Induces FoxM1 Expression and Localization through ERK 1/2, AKT, and p38 Signaling Pathway in HEC-1A Cells
Xie, Yunpeng
Li, Yinghua
Kong, Ying
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (12): : 23345 - 23358
[36] Selective cyclooxygenase 2 inhibitor NS-398 induces apoptosis in myeloma cells via a Bcl-2 independent pathway
Zhang, M
Abe, Y
Matsushima, T
Nishimura, J
Nawata, H
Muta, K
LEUKEMIA & LYMPHOMA, 2005, 46 (03) : 425 - 433
[37] Copy number gain of the MCL1 gene locus (1q21) and acquisition of BCL2 mutation mediate resistance to venetoclax in multiple myeloma (MM) patients
Maity, Ranjan
Neri, Paola
Donovan, Justin
Kong, Madison
Hasan, Fajer
Boise, Lawrence
Bahlis, Nizar J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E22 - E23
[38] PLCG2 promotes hepatocyte proliferation in vitro via NF-κB and ERK pathway by targeting bcl2, myc and ccnd1
Ma, Donghui
Lian, Fang
Wang, Xiaobai
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 3786 - 3792
[39] Overcoming multi-drug resistance in SCLC: a synergistic approach with venetoclax and hydroxychloroquine targeting the lncRNA LYPLAL1-DT/BCL2/BECN1 pathway
Li, Shuxin
Lv, Jianyi
Li, Zhihui
Zhang, Qiuyu
Lu, Jing
Huo, Xueyun
Guo, Meng
Liu, Xin
Li, Changlong
Wang, Jinghui
Shi, Hanping
Deng, Li
Chen, Zhenwen
Du, Xiaoyan
MOLECULAR CANCER, 2024, 23 (01)
[40] MiR-429 regulates rat liver regeneration and hepatocyte proliferation by targeting JUN/MYC/BCL2/CCND1 signaling pathway
Zhang, Chunyan
Chang, Cuifang
Gao, Hang
Wang, Qiwen
Zhang, Fuchun
Xu, Cunshuan
CELLULAR SIGNALLING, 2018, 50 : 80 - 89

← 1 2 3 4 5 →